검색
Nervgen Pharma Ord Shs
NGEN관심 목록에 추가
2.120USD
+0.030+1.44%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
171.78M시가총액
손실P/E TTM
자세한 내용은 Nervgen Pharma Ord Shs 회사
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Nervgen Pharma Ord Shs 정보
종목 코드 NGEN
회사 이름NervGen Pharma Corp
상장일Mar 13, 2019
CEORogers (Adam H)
직원 수- -
유형Ordinary Share
회계 연도 종료- -
주소Suite 1703 - 595 Burrard Street
도시VANCOUVER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Canada
우편 번호V7X 1J1
전화16047225361
웹사이트https://www.nervgen.com/
종목 코드 NGEN
상장일Mar 13, 2019
CEORogers (Adam H)
Nervgen Pharma Ord Shs의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
160.00K
-31.25%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
27.76K
-54.04%
,
,
--
--
Mr. Brian Eric Bayley
Mr. Brian Eric Bayley
Independent Director
Independent Director
--
--
Dr. Harold Martin Punnett
Dr. Harold Martin Punnett
Independent Director
Independent Director
--
--
Mr. William J. (Bill) Adams
Mr. William J. (Bill) Adams
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John Craig Thompson
Mr. John Craig Thompson
Independent Director
Independent Director
--
--
Dr. Adam H. Rogers
Dr. Adam H. Rogers
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Gianni (John) Ruffolo
Mr. Gianni (John) Ruffolo
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
160.00K
-31.25%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
27.76K
-54.04%
,
,
--
--
Mr. Brian Eric Bayley
Mr. Brian Eric Bayley
Independent Director
Independent Director
--
--
Dr. Harold Martin Punnett
Dr. Harold Martin Punnett
Independent Director
Independent Director
--
--
Mr. William J. (Bill) Adams
Mr. William J. (Bill) Adams
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
자주 묻는 질문
Nervgen Pharma Ord Shs의 상위 5대 주주는 누구인가요?
Nervgen Pharma Ord Shs의 상위 5대 주주는 다음과 같습니다: Dr. Randall E. Kaye, M.D.
Nervgen Pharma Ord Shs(NGEN)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Nervgen Pharma Ord Shs의 주식을 보유한 기관은 총 17곳이며, 이들이 보유한 주식의 총 가치는 약 350.93K로 전체 발행 주식의 0.44%를 차지합니다. 이는 2025Q4 대비 303132.00 증가한 수치입니다.